Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations
Open Access
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 37 (1) , 12-17
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute
- Ruth L. Kirschstein National Research Service Award
- Clinical and Translational Science Center at Weill Cornell Medical Center
This publication has 28 references indexed in Scilit:
- Integrated molecular analysis of clear-cell renal cell carcinomaNature Genetics, 2013
- Comprehensive molecular characterization of clear cell renal cell carcinomaNature, 2013
- Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell CarcinomaEuropean Urology, 2013
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- The von Hippel–Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1COncogene, 2011
- Guideline for Management of the Clinical T1 Renal MassJournal of Urology, 2009
- Tumor Size Does Not Predict Risk of Metastatic Disease or Prognosis of Small Renal Cell CarcinomasJournal of Urology, 2008
- A Preoperative Prognostic Nomogram for Solid Enhancing Renal Tumors 7 cm or Less Amenable to Partial NephrectomyJournal of Urology, 2007
- Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imagingUrology, 2006
- Are Small Renal Tumors Harmless? Analysis of Histopathological Features According to Tumors 4 Cm or Less in DiameterJournal of Urology, 2006